Biotechnology Stocks I Performance Guide: ImmunoGen, Inc. (IMGN)
IMGN has no dividends
Table and Chart of IMGN Performance
See what a $1,000 investment in IMGN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| IMGN Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $14.67 |
| End Date | Dec-01-2023 |
| End Price | $29.32 |
| # Prices | 121 |
| Min Date | Nov-30-2016 |
| Min Price | $1.78 |
| Max Date | Nov-30-2023 |
| Max Price | $29.35 |
| Total Return | 99.86% |
| Annualized Return | 7.11% |
| Current Value of $1,000 Purchase | $1,999 |
| Number Returns | 7,260 |
| Average Return | 34.24% |
| Number Profitable Returns | 3,062 |
| Percent Profitable Returns | 42.18% |
| Number Unprofitable Returns | 4,198 |
| Percent Unprofitable Returns | 57.82% |
| Profitable to Unprofitable Returns Ratio | 0.73 |
| IMGN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $7,847,850,000 | Price to Sales | 27.29 |
| Earnings per Share | $-0.2800 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 13.97 |
| PRICE DATA | |
| 52 Week High | $29.44 |
| 52 Week Low | $3.605 |
| Analyst Target Price | $28.31 |
| 50-Day Moving Average | $15.69 |
| 200-Day Moving Average | $12.98 |
| FINANCIAL DATA | |
| Revenue per Share | $1.095 |
| Revenue | $287,614,000 |
| Profit Margin | -25.6% |
| Return on Equity | -0.199% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
IMGN Compare Returns with S&P 500
IMGN Trendline Chart